National Multicentre Study on Lipid Profile in Noonan Syndrome and Related Disorders: Trends by Age, Gender and Genotype
Status: Recruiting
Location: See all (14) locations...
Study Type: Observational
SUMMARY
RASopathies, including Noonan syndrome, involve dysmorphisms, metabolic alterations, and an unfavorable lipid profile. This study investigates lipid and glucose metabolism to improve patient care.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 2
Maximum Age: 35
Healthy Volunteers: f
View:
• Clinically diagnosed RASopathy confirmed by molecular testing;
• Patients referred to participating centers between 01/01/2001 and 31/12/2022;
• Age at enrollment between 2 and 35 years, inclusive;
• Obtaining informed consent.
Locations
Other Locations
Italy
Azienda Ospedaliero-Universitaria di Alessandria
NOT_YET_RECRUITING
Alessandria
AOU Policlinico di Bari
NOT_YET_RECRUITING
Bari
IRCCS Azienda Ospedaliero-Universitaria di Bologna
RECRUITING
Bologna
AOU Meyer IRCCS
RECRUITING
Florence
IRCCS Istituto Giannina Gaslini
RECRUITING
Genova
AOU Policlinico G. Martino
NOT_YET_RECRUITING
Messina
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
NOT_YET_RECRUITING
Milan
IRCCS Ospedale San Raffaele
NOT_YET_RECRUITING
Milan
Azienda Ospedaliera Policlinico di Modena
NOT_YET_RECRUITING
Modena
Fondazione IRCCS San Gerardo dei Tintori
NOT_YET_RECRUITING
Monza
AOU Vanvitelli
NOT_YET_RECRUITING
Naples
Azienda Ospedale-Università di Padova
NOT_YET_RECRUITING
Padova
Azienda Ospedaliero-Universitaria di Parma
NOT_YET_RECRUITING
Parma
AOUI-VR Azienda Ospedaliero-Universitaria Integrata di Verona
NOT_YET_RECRUITING
Verona
Contact Information
Primary
Federica Tamburrino
federica.tamburrino@aosp.bo.it
00390512143723
Time Frame
Start Date: 2025-02-26
Estimated Completion Date: 2027-04-26
Participants
Target number of participants: 200
Related Therapeutic Areas
Sponsors
Leads: IRCCS Azienda Ospedaliero-Universitaria di Bologna